A pooled analysis of the safety of tofacitinib as monotherapy or in combination with background conventional synthetic disease-modifying antirheumatic drugs in a Phase 3 rheumatoid arthritis population
| Image |  |
|---|---|
| Description | scientific article published on 19 July 2018 |
| Author/s |
author: Boulos Haraoui Stanley B Cohen |
| Publication date | July 19, 2018 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |